Isoprostanes in amniotic fluid: A predictive marker for fetal growth restriction in pregnancy

Free Radical Biology and Medicine

Volumn 38, Issue 11, 2005, Pages 1537-1541

  Longini, Mariangela ^a   Perrone, Serafina ^a   Kenanidis, Antonio ^a   Vezzosi, Piero ^a   Marzocchi, Barbara ^a   Petraglia, Felice ^a   Centini, Giovanni ^a   Buonocore, Giuseppe ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Amniotic fluid; Fetal growth restriction; Isoprostanes; Lipid peroxidation; Oxidative stress

Indexed keywords

BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE;

ADULT; AMNION FLUID; ARTICLE; BIOMETRY; BIRTH WEIGHT; COLOR ULTRASOUND FLOWMETRY; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; FETUS; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; OXIDATIVE STRESS; PREDICTION; PREGNANCY; PRIORITY JOURNAL; ROC CURVE; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AMNIOTIC FLUID; BIOMETRY; BIRTH WEIGHT; F2-ISOPROSTANES; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ISOPROSTANES; OXIDATIVE STRESS; PREGNANCY; RISK; ROC CURVE; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER;

EID: 18944375054     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.02.017     Document Type: Article

References (37)

1. Aucott, S. W.; Donohue, P. K.; Northington, F. J. Increased morbidity in severe early intrauterine growth restriction. J. Perinatol. In press.
2. B. Puga, A. Ferrandez Longas, R. Garcia Romero, E. Mayayo, and J.I. Labarta Psychomotor and intellectual development of children born with intrauterine growth retardation J. Pediatr. Endocrinol. Metab. 17 2004 457 462
3. L.G. Thaete, E.R. Dewey, and M.G. Neerhof Endothelin and the regulation of uterine and placental perfusion in hypoxia-induced fetal growth restriction J. Soc. Gynecol. Invest. 11 2004 16 21
4. T.R. Regnault, B. de Vrijer, H.L. Galan, M.L. Davidsen, K.A. Trembler, F.C. Battaglia, R.B. Wilkening, and R.V. Anthony The relationship between transplacental O2 diffusion and placental expression of PlGF, VEGF and their receptors in a placental insufficiency model of fetal growth restriction J. Physiol. 550 2003 641 656
5. G. Buonocore, S. Perrone, M. Longini, L. Terzuoli, and R. Bracci Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies Pediatr. Res. 47 2000 221 224
6. G. Buonocore, S. Perrone, M. Longini, P. Vezzosi, B. Marzocchi, P. Paffetti, and R. Bracci Oxidative stress in preterm neonates at birth and on the seventh day of life Pediatr. Res. 52 2002 46 49
7. G. Buonocore, S. Zani, I. Sargentini, D. Gioia, C. Signorini, and R. Bracci Hypoxia-induced free iron released in the red cells of newborn infants Acta Paediatr. 87 1998 77 81
8. G. Buonocore, S. Zani, S. Perrone, B. Caciotti, and R. Bracci Intraerythrocyte nonprotein-bound iron and plasma malondialdehyde in the hypoxic newborn Free Radic. Biol. Med. 25 1998 766 770
9. G. Buonocore, S. Perrone, M. Longini, P. Paffetti, P. Vezzosi, M.G. Gatti, and R. Bracci Non protein bound iron as early predictive marker of neonatal brain damage Brain 126 2003 1224 1230
10. Y. Takagi, T. Nikaido, T. Toki, N. Kita, M. Kanai, T. Ashida, S. Ohira, and I. Konishi Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction Virchows Arch. Jan. 444 2004 49 55
11. G. Buonocore, S. Perrone, and R. Bracci Free radicals and brain damage in the newborn Biol. Neonate 79 2001 180 186
12. C.C. Winterbourn, T. Chan, I.H. Buss, T.E. Inder, N. Mogridge, and B.A. Darlow Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: associations with chronic lung disease and retinopathy and effects of selenium supplementation Pediatr. Res. 48 2000 84 90
13. K. Moore, and L.J. Roberts II Measurement of lipid peroxidation Free Radic. Res. 28 1998 659 671
14. D. Pratico F2-isoprostanes: Sensitive and specific non-invasive indices of lipid peroxidation in vivo Atherosclerosis 147 1999 1 10
15. J.D. Morrow, and L.J. Roberts The isoprostanes. Current knowledge and directions for future research Biochem. Pharmacol. 12 1996 1 9
16. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr, and I.J. Roberts A series of prostaglandin F2-like compounds are produced in vivo in human by a non cyclooxygenase, free radical-catalyzed mechanism Proc. Natl. Acad. Sci. USA 87 1990 9383 9397
17. S. Basu Radioimmunoassay of 8-iso-PGF2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation Prostaglandins Leukot. Essent. Fatty Acids 58 1998 319 325
18. J.D. Morrow, J.A. Awad, H.J. Boss, I.A. Blair, and L.J. Robert II Non cyclooxigenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids Proc. Natl. Acad. Sci. USA 89 1992 10721 10725
19. J.D. Morrow The isoprostanes: their quantification as an index of oxidant stress status in vivo Drug. Metab. Rev. 32 2000 377 385
20. 2α and platelet activation in diabete mellitus: effects of improved metabolic control and vitamin E supplementation Circulation 99 1999 224 229
21. A.A. Nanji, S. Khwaja;, S.R. Tahan;, and S.M. Sadrzadeh Plasma levels of a novel non cyclooxigenase derived prostanoid (8-iso-prostane) correlate with severity of liver injury in experimental alcoholic liver dosage J. Pharmacol. Exp. Ther. 269 1994 1280 1285
22. C.T. Carpenter, P.V. Price, and B.W. Christman Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS Chest 114 1998 1653 1659
23. 2-isoprostane in Alzhaimer's disease: evidence for enhanced lipid peroxidation in vivo FASEB J. 12 1998 1777 1783
24. 2α on retinal vessels Am. J. Physiol. 274 1998 R1406 R1416
25. E. Bertino, E. Di Battista, A. Bossi, M. Pagliano, C. Fabris, G. Aicardi, and S. Milani Fetal growth velocity: kinetic, clinical, and biological aspects Arch. Dis. Child Fetal Neonatal Ed. 74 1996 F10 F105
26. F.C. Battaglia, and L.O. Lubchenco A practical classification of newborn infants by weight and gestational age J. Pediatr. 71 1967 159 163
27. M.G. Neerhof Causes of intrauterine growth restriction Clin. Perinatol. 22 1995 375 385
28. L. Myatt, W. Kossenjans, R. Sahay, A. Eis, and D. Brockman Oxidative stress causes vascular dysfunction in the placenta J. Matern. Fetal. Neonatal Med. 9 2000 79 82
29. D. Maulik, Y. Numagami, S.T. Ohnishi, O.P. Mishra, and M. Delivoria-Papadopoulos Direct detection of oxygen free radical generation during in utero hypoxia in the fetal guinea pig brain Brain Res. 798 1998 166 172
30. O.P. Mishra, and M. Delivoria-Papadopoulos Lipid peroxidation in developing fetal guinea pig brain during normoxia and hypoxia Dev. Brain Res. 45 1989 129 135
31. S.W. Walsh Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia Semin. Reprod. Endocrinol. 16 1998 93 104
32. L. Myatt, A.L. Eis, D.E. Brockman, W. Kossenjans, I.A. Greer, and F. Lyall Differential localization of superoxide dismutase isoforms in placental villous tissue of normotensive, pre-eclamptic, and intrauterine growth-restricted pregnancies J. Histochem. Cytochem. 45 1997 1433 1438
33. A. Karowicz-Bilinska, U. Kowalska-Koprek, J. Suzin, and P. Sieroszewski Analysis of 8-isoprostane concentration as a marker of oxidative stress in pregnant women diagnosed with IUGR Ginekol. Pol. 74 2003 1137 1142
34. M.T. Coughlan, P.P. Vervaart, M. Permezel, H.M. Georgiou, and G.E. Rice Altered placental oxidative stress status in gestational diabetes mellitus Placenta 25 2004 78 84
35. R. Bracci, and G. Buonocore The antioxidant status of erythrocytes in preterm and term infants Semin. Neonatol. 3 1998 191 197
36. G. Buonocore, and S. Perrone Biomarkers of hypoxic brain injury in the neonate Clin. Perinatol. 31 2004 107 116
37. M. Comporti, C. Signorini, S. Leoncini, G. Buonocore, V. Rossi, and L. Ciccoli Plasma F2-isoprostanes are elevated in newborns and inversely correlated to gestational age Free Radic. Biol. Med. 37 2004 724 732